Status | Study |
Suspended |
Study Name: Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata Condition: Alopecia Areata Date: 2017-04-28 Interventions: Drug: CTP-543 tablets |
Recruiting |
Study Name: Design and Validation of a New Assessment Tool for Lichen Planopilaris Condition: Lichen Planopilaris of Scalp Lichen Plano-Pilaris Lichen P Date: 2017-03-13 Interventions: Diagnostic Test: Boston Grade of Activity in Lichen Planopilaris A clinical assessment tool to objective |
Recruiting |
Study Name: Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata Condition: Alopecia Areata Scarring Alopecia Date: 2017-03-06 Interventions: Procedure: tSVF by lipoaspiration |
Recruiting |
Study Name: Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females Condition: Hair Loss Date: 2017-02-10 Interventions: Dietary Supplement: Nutrafol E |
Recruiting |
Study Name: The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia Condition: Androgenetic Alopecia Date: 2017-02-07 Interventions: Device: Platelet Rich Plasma Prep System |
Recruiting |
Study Name: Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia Condition: Alopecia, Androgenetic Date: 2016-12-23 Interventions: Drug: P-3074 Other Name: finas |
Active, not recruiting |
Study Name: Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic Alopecia Condition: Androgenetic Alopecia Date: 2016-12-19 Interventions: Biological: Platelet Rich Plasma for 4 sessions |
Enrolling by invitation |
Study Name: Barriers to Care and QOL for CCCA Patients Condition: Scarring Alopecia Central Centrifugal Cicatricial Date: 2016-12-16 Interventions: Other: 53-Item Survey |
Active, not recruiting |
Study Name: A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2) Condition: Alopecia Chemotherapy Effects Date: 2016-12-06 Interventions: Other: CG428 The experimental group will receive CG428. For each application, the patient should shake t |
Recruiting |
Study Name: Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata Condition: Alopecia Areata Date: 2016-11-23 Interventions: Drug: PF-06651600 200 mg QD du |